Citicoline (CDP ‐choline) add‐on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double‐blind, randomized placebo‐controlled trial

Human Psychopharmacology: Clinical and Experimental, EarlyView.

Source: Human Psychopharmacology: Clinical and Experimental - June 14, 2018 Category: Psychiatry Authors: AlirezaGhajar , FaezehGholamian , MaryamTabatabei ‐Motlagh , MohsenAfarideh , FarzinRezaei , MaryamGhazizadeh‐Hashemi , ShahinAkhondzadeh Source Type: research